By Mill Chart
Last update: Feb 12, 2024
Take a closer look at GILEAD SCIENCES INC (NASDAQ:GILD), a stock of interest to dividend investors uncovered by our stock screener. NASDAQ:GILD excels in fundamentals and provides a decent dividend, all while maintaining a reasonable valuation. Let's break it down further.
To gauge a stock's dividend quality, ChartMill utilizes a Dividend Rating ranging from 0 to 10. This comprehensive assessment considers various dividend aspects, including yield, history, growth, and sustainability. NASDAQ:GILD has achieved a 7 out of 10:
A critical element of ChartMill's stock evaluation is the Health Rating, which spans from 0 to 10. This rating considers multiple health factors, including liquidity and solvency, both in absolute terms and relative to industry peers. NASDAQ:GILD has received a 5 out of 10:
ChartMill assigns a Profitability Rating to every stock. This score ranges from 0 to 10 and evaluates the different profitability ratios and margins, both absolutely, but also relative to the industry peers. NASDAQ:GILD scores a 7 out of 10:
Our Best Dividend screener lists more Best Dividend stocks and is updated daily.
For an up to date full fundamental analysis you can check the fundamental report of GILD
Important Note: The content of this article is not intended as trading advice. It is essential to perform your own analysis and exercise caution when making trading decisions. The article presents observations created by automated analysis but does not guarantee any trading or investment outcomes. Always trade responsibly and make independent judgments.
GILEAD SCIENCES INC
NASDAQ:GILD (4/23/2024, 7:01:49 PM)
After market: 66.71 -0.32 (-0.48%)67.03
+0.08 (+0.12%)
Three of Wall Street's undervalued stocks could provide a unique blend of stability and long-term growth potential.
Investors' focus is likely to be on Gilead's (GILD) HIV franchise performance and oncology sales when the company reports first-quarter 2024 results.
Gilead Sciences (GILD) closed the most recent trading day at $66.76, moving +0.91% from the previous trading session.
Gilead Sciences (GILD) closed at $66.16 in the latest trading session, marking a -1.15% move from the prior day.
Gilead (GILD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Uncovering Dividend Opportunities with GILEAD SCIENCES INC (NASDAQ:GILD).
Merck's shares are trading in bargain territory. Are they a better growth play than this popular Vanguard fund?
Dividend stocks can be a smart way to ride out market volatility.
EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:GILD),(NASDAQ:GTHX),(NASDAQ:AZN),(NASDAQ:HOLX) EQNX::TICKER_END